{"name":"Visen Pharmaceuticals (Shanghai) Co., Ltd.","slug":"visen-pharmaceuticals-shanghai-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"TransCon PTH","genericName":"TransCon PTH","slug":"transcon-pth","indication":"Treatment of osteoporosis in men and women","status":"phase_3"}]}],"pipeline":[{"name":"TransCon PTH","genericName":"TransCon PTH","slug":"transcon-pth","phase":"phase_3","mechanism":"TransCon PTH is a long-acting parathyroid hormone analogue designed to mimic the natural physiological profile of endogenous parathyroid hormone.","indications":["Treatment of osteoporosis in men and women"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxOd1p5eUVSN2hiWWtQVTRtdUpxaWExSXZ6OHJfd3U4eFVrWFdxeGtLMlNUa2diSFZBeFZ2bTJQb1U4Z3pVNDQzRldaMUhtSVQ1bHZMY0FabXZaOUhBNFV3bDI1NEdnWC0zaXhuWmRmRXFVMzJIc29hMmlFeU5Pd0QxYzRUWTkzbVE?oc=5","date":"2025-09-19","type":"pipeline","source":"BioWorld News","summary":"Genfleet raises $234M with Hong Kong IPO - BioWorld News","headline":"Genfleet raises $234M with Hong Kong IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQejVOQWEzZlFvQV9sYlB3ZkpsbC1MdVk2aDBLa2gxOVF2S3RiT0dHUURIOWc3VVUzWGgyNHVOUVFfVW5WYmdiNlYtdVp0M2k3M25Rb2JldERDQTZnVGhiSUZveDlGOGRRdVB4cHhIRWNwXzRtU0YyeHlZWW5YeHB3WjBwWVhBY1pWT09oek1heGhzNnVuMHVibGl6Vy03YUk?oc=5","date":"2025-09-09","type":"pipeline","source":"BioWorld News","summary":"Biopharma IPO activity slows, but 2025 returns are surging - BioWorld News","headline":"Biopharma IPO activity slows, but 2025 returns are surging","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTFBSVnZLaTRfckNIZGZad1M2b1kwLURzYVYycjVZbVhHVzNIdk9jYUVqaktYa0VpdWZqZThwQldiWFhGRVZoUVl0cDlnMHJNWXhIanRHQ0lB?oc=5","date":"2025-07-31","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Ab&B Bio-Tech CO., LTD. JS (2627.HK) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Ab&B Bio-Tech CO., LTD. JS (2627.HK) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQbTBYUFotVDBCU2ZNSEhqc0Y4VUkwS2t1UmR3MnNibXBWSWdJTWNuUGJWajBoNHllRzA2blJ6UEk0QWRVUEFVeDVfM3JkdEZ3Vk5lYVAwOVFkQmt6WUdxeEt5VHBvV3BVVXpFc3l2dFc2WGlFeTZ2aXF4b2I2anNiRVNsVnI4cndqczd3dG1FSC1yLU9fUTI3WmxkekdtOFh4d1MxSQ?oc=5","date":"2025-06-24","type":"pipeline","source":"BioWorld News","summary":"Transthera raises $25M with Hong Kong IPO; stock up 78% on debut - BioWorld News","headline":"Transthera raises $25M with Hong Kong IPO; stock up 78% on debut","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQUEppcmhXQlRueTBrMEU5a01vV0xCenBKXzVwNG80aHREX0JpdEM4RkFta1h5RTFxX0NTWVg3T3l0Z0F5T3M4YTZxdGJiV3dHZFluckNOdjlSYS1QX3BPajQydUlVaWlqVElJaHJFS2QzNlA4OHNSWV96U3dQb1hwcEhYSHpZeFVVWTZWR3dHalVHMElSU1dxN1NRUzhQTGN0OS1J?oc=5","date":"2024-10-24","type":"pipeline","source":"BioWorld News","summary":"Yorvipath-finders? Septerna, others forge on in hypothyroidism - BioWorld News","headline":"Yorvipath-finders? Septerna, others forge on in hypothyroidism","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE8xVFY3Wjl4bzJwSW8zeXJUM1B0NnZWdFdfTXY5YnZNYzgzTUYwZVhOOVFDR2pSdF85UzR0Q3ByVkw1Y0lrVDNONnJlclN3WWs4VnhZZVZR?oc=5","date":"2017-06-12","type":"pipeline","source":"Yahoo Finance Singapore","summary":"China Shineway Pharmaceutical Group Limited (2877.HK) stock price, news, quote and history - Yahoo Finance Singapore","headline":"China Shineway Pharmaceutical Group Limited (2877.HK) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE5waEFOQUFkbDJKZDV2bzN4Mnp3aVYxcVFXbjAzSFBGbzk3bmxsajM5dW9NRmplTG55QkVvdnVBaXhReDJmOG1nWVE5bDdYY1lyeHV1UU1n?oc=5","date":"2017-06-12","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Consun Pharmaceutical Group Limited (1681.HK) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Consun Pharmaceutical Group Limited (1681.HK) stock price, news, quote and history","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}